<DOC>
	<DOCNO>NCT02157129</DOCNO>
	<brief_summary>Patients tracheostomy represent substantial part ear nose throat clinic . Long-term intubated patient intensive care unit also profit tracheostomy due improve respiratory toilet . However , tracheostomy patient demonstrate shunt ventilation bypass sinonasal pharyngeal system . The physiological moistening , clean warm breathe air fail result respiratory inflammation . Beside variety supportive medical device general recommendation exist present . Recently , demonstrate beneficial application local phospholipid Sjoegren 's syndrome antineutrophil cytoplasmatic antibody associate sinonasal vasculitis . In current monocentric , two-armed , double-blinded , randomized parallel group study would like evaluate beneficial application LipoAerosol© compare standard physiologic saline inhalation . LipoAerosol© license , tradable medical device apply part intend use . Liposomal inhalation solution provide moistening , clean warm upper low respiratory tract support natural moistening film airway irritation disease . Blood parameter ( leucocytes c reactive protein ) tracheobronchial secretion ( Lymphocyte subpopulation , c reactive protein , lactate dehydrogenase , granulocyte macrophage colony stimulate factor , interferon γ , interleukins 10 , 12 ( p70 ) , 13 , 1β , 2 , 4 , 5 , 6 , 7 , 8 , tumor necrosis factor α ) collect 1 , 3 , 10 day tracheostomy . In addition , medical examination record number suction maneuver ( 0 point : none ; 1 point : 5-10x/d ; 2 point : 10-20x/d ; 3 point : &gt; 20x/d ) , flexible-optical assessment tracheo-bronchial redness ( 0 point : none ; 1 point : peristomal ; 2 point : tracheal ; 3 point : tracheo-bronchial ) flexible-optical assessment mucous congestion ( 0 point : none ; 1 point : fluent ; 2 point : tenacious ; 3 point : barky ) . Subjective estimation respiratory impairment analyze via visual analogue scale ( Subjective overall impairment , cough frequency , breathlessness , mucous congestion , color sputum , consistency sputum ) . The study design without additional invasive incriminate clinical examination . Aim study maintain functional integrity tracheo-bronchial system tracheostomy use LipoAerosol© result general therapeutic recommendation .</brief_summary>
	<brief_title>LipoAerosol© Inhalation After Tracheostomy</brief_title>
	<detailed_description />
	<mesh_term>Respiratory Aspiration</mesh_term>
	<mesh_term>Postoperative Complications</mesh_term>
	<criteria>Patients ≤24h tracheostomy regular patient 's consent No regular patient 's consent Known allergy ingredient Patients &gt; 24h tracheostomy Patients acute imminent sepsis Patients exist bronchopulmonary inflammation Patients immunosuppressive therapy Patients poorly adjust pulmonary disease Patients chronic respiratory insufficiency</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Tracheostomy</keyword>
	<keyword>inflammation</keyword>
	<keyword>mucous congestion</keyword>
	<keyword>inhalation therapy</keyword>
	<keyword>phospholipid</keyword>
</DOC>